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Objective: Serum LDL conjugated diene concentration is a marker of oxidative modiﬁcation of LDL. We
investigated the relationship between LDL conjugated dienes and cross-sectional subclinical athero-
sclerosis assessed by carotid IMT in high-risk subjects of a multicenter study.
Methods: Serum LDL conjugated dienes and ultrasonographically assessed carotid intimaemedia thick-
ness (IMTmean, IMTmax and IMTmean-max) were available for 553 subjects from Finland, France, Italy, the
Netherlands, and Sweden.
Results: In multivariate regression analysis, gender (p < 0.001), age (p < 0.001), systolic blood pressure
(IMTmean, p ¼ 0.01; IMTmean-max, p ¼ 0.05) and serum LDL conjugated dienes (p ¼ 0.02 for both IMTmean
and IMTmean-max) were the strongest determinants of IMT variation, adjusted for study center, ultrasound
videotape reader and serum LDL cholesterol. Pack-years of smoking, added into the regression model, did
not destroy the signiﬁcant association between increased serum LDL conjugated dienes and IMT. Ratio of
LDL conjugated dienes to LDL particle cholesterol was higher in subjects of Northern recruiting centers
than of Southern centers (r ¼ 0.39, p < 0.0001).
Conclusions: There was a cross-sectional association between in vivo increased LDL oxidative modiﬁca-
tion and subclinical atherosclerosis after adjustment for traditional risk factors. The subjects in Northern
countries of Europe had more oxidatively modiﬁed lipids per cholesterol in LDL particle than subjects in
Southern countries.
 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Hypercholesterolemia, especially high concentration of serum
low-density lipoprotein (LDL) cholesterol has been considered onelth and Clinical Nutrition,
1 Kuopio, Finland. Tel.: þ358
ssönen).
der the Elsevier OA license.of the major factors of atherosclerosis. However, oxidative modiﬁ-
cation of LDL has appeared to have an important role in the early
development of atherosclerosis, through the formation of
macrophage-derived foam cells on the arterial wall [1,2]. Macro-
phages bind and take up oxidative modiﬁed LDL particles via
scavenger receptors, but not unoxidized, native LDL particles [3].
There are probably several stages of oxidative modiﬁcation of
LDL particles in circulation, which lead to numerous changes in the
structure of oxidized LDL particles. A lot of biomarkers for the
measurement of lipid oxidation in human blood have been intro-
duced, including the measurement of autoantibodies to oxidized
K. Nyyssönen et al. / Atherosclerosis 225 (2012) 231e236232LDL [4e7] and LDL conjugated dienes [8,9]. Formation of conju-
gated dienes in LDL is one of the earliest steps in the oxidative
modiﬁcation of LDL lipids. Recently, association of LDL conjugated
dienes with markers of atherosclerosis, e.g. intimaemedia thick-
ness (IMT) or arterial elasticity has been examined in several
studies, but with quite a small number of subjects [10e13].
This is a substudy of the IMPROVE project that is a multicenter,
observational study to evaluate the association between athero-
sclerosis and biochemical, genetic, nutritional, behavioral and
psychosocial factors in ﬁve European countries. The aim of this
study is to assess the relationship between serum LDL conjugated
dienes and cross-sectional subclinical atherosclerosis assessed by
carotid IMT in high-risk subjects.
2. Methods
2.1. Study subjects
The design, primary and secondary objectives and eligibility
criteria and baseline evaluation of the IMPROVE study were
described previously [14].
Brieﬂy, the IMPROVE study enrolled 3711 individuals, aged from
54 to 79 years, with at least three vascular risk factors (VRF),
asymptomatic for cardiovascular diseases and free of any condi-
tions that might limit longevity (e.g. cancer) or IMT visualization.
For this substudy, at baseline visit, every sixth consecutive random
subject in each recruiting center gave a blood sample for serum LDL
conjugated diene measurement. There were 148 subjects from two
centers in Kuopio, Finland; 102 from Stockholm, Sweden; 42 from
Groningen, the Netherlands; 87 from Paris, France; 86 from Milan,
Italy and 88 from Perugia, Italy. The IMT measurements were
available for all these 553 subjects.
The study complies with the rules of Good Clinical Practice and
with the ethical principles established in the Declaration of Hel-
sinki and was approved by local ethics committees in each study
center. All patients gave written informed consents.
2.2. Biochemical assays
Blood samples were drawn and handled in each study center
according to the standard operation procedure for IMPROVE study
[14]. Blood was drawn after an overnight fast.
For serum LDL conjugated diene measurement [15], blood was
drawn in serum tubes and samples were centrifuged within 30 min
after blood collection. After separation of serum,12 ml of 100 mg/ml
ethylenediamine tetra acetic acid (EDTA) was added to 1.2 ml of
serum to avoid ex vivo oxidative modiﬁcation of LDL. Serum
samples with EDTAwere frozen at80 C at the study centers until
sending them for analysis to the Laboratory of the Research Insti-
tute of Public Health, University of Kuopio, Finland. Brieﬂy, serum
LDL was precipitated with buffered heparin. The precipitate was
resuspended in 0.10 M phosphate buffered saline, pH 8.0. Choles-
terol concentration of the suspension was determined with an
enzymatic colorimetric method by Konelab analyzer (Thermo
Fisher Scientiﬁc, Vantaa, Finland) and the rest of the suspension
was used for measuring conjugated dienes. Lipids were extracted
from the LDL with the mixture of chloroform:methanol (3:1),
evaporated to dryness and reconstituted in cyclohexane. The
concentration of conjugated dienes was measured spectrophoto-
metrically at 234 and 300 nm. The between day variationwas 15.7%
for a serum pool at the conjugated diene level of 31.3 mmol/l, n¼ 97.
Plasma glucose concentration was measured locally in each
study center. Serum for total and HDL cholesterol, triglyceride and
high sensitivity C reactive (hs-C reactive) protein measurements
was frozen prior to shipment for centralized biochemical analysesin Stockholm (Karolinska Institute, Stockholm, Sweden). Serum
concentration of HDL cholesterol and triglycerides were analyzed
with an LX Beckman Instrument by enzymatic colorimetric
methods and hs-C reactive protein by an immunoturbidimetric
method. Serum LDL cholesterol was calculated by Friedewald’s
formula.
2.3. Ultrasonography variables
Carotid ultrasound was performed in each of the seven study
centers using a Technos system (Esaote, Genoa, Italy) equipped
with a 5e10 MHz linear array probe. The far walls of the left and
right common carotid (CC), the bifurcation (Bif) and the internal
carotid artery (ICA) were visualized in anterior, lateral and posterior
projections and recorded on sVHS videotapes. IMT measurements
on the videotapes were performed in a centralized laboratory
(Department of Pharmacological Sciences, University of Milan,
Italy) using a dedicated software (M’Ath, Metris SRL, France). The
far walls of the CCs (the entire length), the Bifs and the ﬁrst prox-
imal centimeter of the ICAs were measured in at least three
different frames. The ultrasonographic variables selected for this
substudy were the mean and maximum IMT of the whole carotid
tree (IMTmean and IMTmax, respectively). Themean of themaximum
IMT values of the whole carotid tree (IMTmean-max) was also
considered.
Most participants were followed throughout the study by the
same sonographer, and all scans for each patient were assigned to
a single reader. The quality control and repeatability of the
measurements were described in detail earlier [14]. Shortly, the
intra-sonographer correlation coefﬁcients for duplicate scans were
0.96 and 0.95 for IMTmean and IMTmax, respectively. The inter-
sonographer correlation coefﬁcients for the same carotid
segments were 0.86 and 0.60, respectively.
2.4. Anthropometric and dietary measurements
Resting blood pressure was measured in the morning by trained
nurses. Body mass index (BMI) was computed as the ratio of weight
(kg) to the square of height (m). The lifelong exposure to smoking
(pack-years) was estimated as packs per day multiplied by number
of years smoked. Consumption of foodstuffs and medication were
recorded in a semi-quantitative way by using a food frequency
questionnaire [14].
2.5. Statistics
All quantitative variables were presented as mean  SD.
Difference in the mean values of subject’s characteristics and use of
foodstuffs between men and womenwas tested by Student’s t-test.
Skewed distributions of IMT variables and serum LDL conjugated
dienes were logarithmically transformed before association anal-
ysis. Associations between serum LDL conjugated dienes and other
subject characteristics were estimated by Pearson’s correlation
coefﬁcients. Multivariate regression analysis was used to determine
the association of known VRFs and serum LDL conjugated dienes
between IMT measurements (IMTmean, IMTmax, and IMTmean-max).
Missing VRFs (at most two missing values per variable) were
replaced by mean value of the variable. Blood pressure was divided
by 10 before regression analysis to obtain relevant IMT changes
against every 10 mmHg changes of blood pressure. Tests for
statistical signiﬁcance were two-sided and p < 0.05 was taken as
the criterion of signiﬁcance (SPSS Statistics software, version 19.0,
Chicago, IL, USA).
Because the amount of conjugated dienes in serum LDL is
strongly dependent on the amount of LDL particles in serum, we
Table 2
Consumption of foodstuffs of the study subjects, n ¼ 553.
Mean  standard deviation
Wine (dl/day) 1.2  2.0
Beer (dl/day) 0.5  1.4
Spirits (dl/day) 0.07  0.24
Milk (dl/day) 2.5  2.1
Coffee (times a day) 2.2  1.4
Tea (times a day) 0.5  0.9
Fruit (pieces/day) 2.3  1.4
Meat (times a week) 3.7  1.9
Fish (times a week) 1.8  1.2
Eggs (times a week) 1.5  1.3
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aliquot as conjugated dienes, and determined the association
between serum LDL conjugated dienes (mmol/mmol cholesterol)
and the geographical latitude of the study centers.
3. Results
Mean age of the subjects was 64 years and about half of them
were male (Table 1). The inclusion criteria of the subjects included
at least three VRF, thus mean values of systolic blood pressure,
serum LDL cholesterol, triglycerides and plasma glucose were quite
high. There were no signiﬁcant differences in the mean values of
age, systolic blood pressure, BMI, serum hs-C reactive protein and
LDL conjugated dienes presented in Table 1 between men and
women (data not shown). However, men had signiﬁcantly higher
IMT values, serum LDL cholesterol, triglycerides and plasma glucose
and lower HDL cholesterol than women. The use of foodstuffs is
presented in Table 2. Men used more wine, beer and spirits, and
more often coffee and meat than women, but there was no differ-
ence in the use of ﬁsh and eggs between genders. No considerable
difference in the results of men or women was found in a prelimi-
nary association analysis, thus the sexes were combined for the
analysis presented in this paper.
Serum LDL conjugated dienes had signiﬁcant direct correlations
with IMT measurements (Table 3). Serum LDL conjugated dienes
correlated strongly with serum triglycerides, LDL cholesterol and
inversely with HDL cholesterol. There were no correlations
between LDL conjugated dienes and age, gender, systolic blood
pressure or serum hs-C reactive protein. Therewere also signiﬁcant
correlations between IMT measurements and systolic blood pres-
sure, plasma glucose or pack-years of smoking.
In addition to variables presented in Table 3, we assessed
Pearson’s correlations between serum LDL conjugated dienes and
several nutritional variables and pharmacological treatment. Of the
nutritional variables (including wine, beer, spirits, fruit, milk,
coffee, tea, meat, ﬁsh, egg) and drugs (including statins, ﬁbrates,
ﬁsh oil, other lipid lowering drugs, beta-blockers, calcium-antag-
onists, ACE inhibitors, angiotensin II inhibitors, diuretics, diabetes
medication, anticoagulants, analgesics, estrogens) only the use of
ﬁsh (R ¼ 0.09, p ¼ 0.039), statins (R ¼ 0.10, p ¼ 0.016) and
calcium antagonists (R ¼ 0.14, p ¼ 0.001) had signiﬁcant corre-
lations with serum LDL conjugated diene concentration.
The relevant variables that correlated signiﬁcantly with IMT
measurements were chosen for themultivariate regression analysis
to ﬁnd out the determinants of the three IMT variables (Table 4).
Gender, age, systolic blood pressure and serum LDL conjugated
dienes were the strongest determinants of IMTmean and IMTmean-Table 1
Characteristics of the study subjects, n ¼ 553.
Mean  standard deviation or %
Gender (male%) 52
Age (years) 64  5
Systolic blood pressure (mmHg) 141  19
Diastolic blood pressure (mmHg) 82  10
BMI (kg/m2) 26.9  4.0
Pack-years 12.6  19.6
Serum LDL cholesterol (mmol/l) 3.53  1.00
Serum HDL cholesterol (mmol/l) 1.28  0.37
Serum triglycerides (mmol/l) 1.52  1.04
Plasma glucose (mmol/l) 6.0  1.8
Serum hs-C reactive protein (mg/l) 2.89  5.00
Serum LDL conjugated dienes (mmol/l) 35.1  10.3
IMTmean (mm) 0.89  0.18
IMTmax (mm) 2.02  0.73
IMTmean-max (mm) 1.41  0.37max in the model, adjusted for recruiting center, ultrasound video-
tape reader and serum LDL cholesterol (Model 1). Systolic blood
pressure did not associate with IMTmax, and the association
between conjugated dienes and IMTmax was only borderline
signiﬁcant. The association between conjugated dienes and
IMTmean, IMTmax and IMTmean-max remained signiﬁcant, also when
blood glucose (Model 2) or pack-years (Model 3) were added into
the model. Model 1 explained 18.2%, 11.3% and 14.3% of the varia-
tions of IMTmean IMTmax and IMTmean-max, respectively. Model 3,
including pack-years, explained IMT variations 21.3% (IMTmean),
12.8% (IMTmax) and 17.5% (IMTmean-max).
The LDL conjugated dienes to LDL particle cholesterol ratio
(mmol/mmol cholesterol) was higher in northern than in southern
recruiting centers (Fig. 1). The linearity of the trend across latitude
was statistically signiﬁcant, R ¼ 0.39 p < 0.0001. Without adjust-
ment with LDL particle cholesterol, the association between LDL
conjugated dienes (mmol/l) and latitude was weaker, but nearly
signiﬁcant, R ¼ 0.078, p ¼ 0.06.
4. Discussion
In this multi-center studywith 553 high risk elderly subjects, we
observed signiﬁcant associations between carotid IMT and oxida-
tive modiﬁcation of LDL measured as serum LDL conjugated dienes.
Plasma glucose concentration had only minor reducing effect on
the association between conjugated dienes and IMT, and hs-C
reactive protein did not associate with IMT.
Our results are in line with the earlier ﬁndings of the association
between increased carotid IMT and serum LDL conjugated dienes
[10,16]. Toikka et al. also demonstrated increased serum levels of
LDL conjugated dienes in borderline hypertensive subjects [10].
No signiﬁcant correlation between LDL conjugated dienes and
carotid IMT was found in a study with 38 diabetic and an equal
number of control subjects [12]. The lack of association in their
results may at least partly be due to the use of LDL cholesterol
adjustment of conjugated dienes before the regression analysis. The
adjustment with the cholesterol or apolipoprotein B content of the
same fraction, where dienes are measured, is often used as an
“internal standard” to correct the possible loss of LDL particles
during LDL precipitation process [8,15]. The correlation between
conjugated dienes and cholesterol in LDL particles is quite high,
thus the correction may diminish the strength of the association
and destroy the signiﬁcance between conjugated dienes and the
outcome.
In early atherosclerosis, an extracellular accumulation of LDL-
derived lipids in the form of small lipid droplets and vesicles can
lead to the development of atherosclerotic lesions in the arterial
intima. Modiﬁed LDL has been recognized to be needed for the
initiation of lipid accumulation [3]. Modiﬁcation of circulating LDL
occurs primarily at the vascular endothelium rather than in plasma,
which contains several endogenous and exogenous antioxidants.
Table 3
Pearson’s correlation coefﬁcients between IMT measurements and vascular risk factors, n ¼ 553.
Age SPB BMI Pack-years HDL TG LDL Gluc CRP IMTmean IMTmax IMTmean-max Log dienes
Gender (male ¼ 1) ns ns ns 0.31b 0.38b ns 0.20b 0.21b ns 0.27b 0.22b 0.26b ns
Age 0.13b ns ns 0.09a 0.09a ns ns ns 0.21b 0.19b 0.19b ns
Systolic blood pressure (SPB) 0.24b ns ns ns 0.09a 0.25b ns 0.21b 0.12b 0.18b ns
BMI ns 0.22b 0.17b 0.13b 0.30b 0.14b ns ns ns 0.12b
Pack-years 0.23b 0.13b ns 0.14b 0.09a 0.26b 018b 0.23b 0.09a
Serum HDL cholesterol (HDL) 0.38b 0.15b ns 0.08a 0.21b 0.15b 0.17b 0.29b
Serum triglycerides (TG) ns ns ns ns ns ns 0.55a
Serum LDL cholesterol (LDL) 0.10a ns ns ns ns 0.23b
Blood glucose (Gluc) ns 0.17b 0.10a 0.14b 0.09a
Serum hs-C reactive protein (CRP) 0.09a 0.10a 0.10a ns
IMTmean 0.82b 0.91b 0.13b
IMTmax 0.90b 0.11b
IMTmean-max 0.12b
ns ¼ not signiﬁcant. Log dienes ¼ Logarithmic transformed serum LDL conjugated dienes.
a Correlation is signiﬁcant at the 0.05 level (2-tailed).
b Correlation is signiﬁcant at the 0.01 level (2-tailed).
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oxidatively modiﬁed LDL, but not native LDL, and oxidatively
modiﬁed LDL accumulation into macrophages lead to formation of
foam cells and subsequent atherosclerosis. LDL modiﬁcation can
exist in protein or lipid part of it. The molecular and chemical
structure of oxidatively modiﬁed LDL varies a lot and has been led
to several analytes and methods for the measurement of oxida-
tively modiﬁed LDL. We measured the amount of LDL conjugated
dienes (rearrangement of double bonds in polyunsaturated fatty
acids) which are early modiﬁcation products of LDL oxidation. The
measurement of conjugated dienes and the determinants of its
serum concentration have been validated and used previously in
our laboratory [15] and was chosen for the method of assessing the
lipid peroxidation status in IMPROVE study. Quantiﬁcation of other
lipid peroxidation analytes like lipid hydroperoxides, hydroxy fatty
acids and F2-isoprostanes would demand liquid or gas chromato-
graphic equipment. Assays of serum oxidized LDL levels are mostly
immunological and the results depend on the antibody used.
Oxidative modiﬁcation of protein part of LDL has also beenTable 4
Association of vascular risk factors with IMT measurements of 553 subjects, based on m
Log IMTmean
b Stand. b p-val
Model 1
Gender (male ¼ 1) 0.046 0.269 <0.00
Age (years) 0.004 0.218 <0.00
Systolic blood pressure (per 10 mmHg variation) 0.005 0.117 0.012
Serum LDL cholesterol (mmol/l) 0.004 0.047 0.283
Log dienes 0.068 0.094 0.025
Model 2
Gender (male ¼ 1) 0.044 0.256 <0.00
Age (years) 0.004 0.218 <0.00
Systolic blood pressure (per 10 mmHg variation) 0.005 0.110 0.019
Serum LDL cholesterol (mmol/l) 0.006 0.065 0.144
Blood glucose (mmol/l) 0.005 0.092 0.042
Log dienes 0.063 0.087 0.038
Model 3
Gender (male ¼ 1) 0.037 0.215 <0.00
Age (years) 0.004 0.220 <0.00
Systolic blood pressure (per 10 mmHg variation) 0.006 0.123 0.008
Serum LDL cholesterol (mmol/l) 0.005 0.051 0.235
Pack-years 0.001 0.191 <0.00
Log dienes 0.059 0.081 0.049
Study center and ultrasound videotape reader were entered as dummy variables into each
IMT measurements were log-transformed, the regression coefﬁcients represent the ex
a coefﬁcient of 0.01 means that IMT is expected to increase by 1% for a unit increment omeasured as serum concentration of carbamylated LDL, but the
method demands a rather big volume of serum and ultracentrifu-
gation or preparation of antibody for immunologic measurement.
In IMPROVE study, the analyte for assessing LDL oxidative modiﬁ-
cation had to stand freezing and the handling of the sample in
recruiting centers had to be simple before sending the sample to
the centralized analyzing laboratory.
In our study, serum LDL cholesterol concentration had no
association with any IMT measurement. Even though LDL choles-
terol is an important and signiﬁcant risk factor of atherosclerosis
[17], the opposite results with minor and non-signiﬁcant associa-
tions with carotid IMT have been previously observed [18]. That
gives rise to the thought that the amount of LDL cholesterol in
circulation, in such, might not be a risk factor of atherosclerosis, if
the oxidative modiﬁcation of it would not exist. In theory, lowering
of oxidatively modiﬁed LDL in blood would retard or prevent the
progression of atherosclerosis. Cholesterol lowering statin therapy
has been suggested to lower the levels of oxidized LDL, but the
latest studies have not found a clear association between statinultivariate regression models.
Log IMTmax Log IMTmean-max
ue b Stand. b p-value b Stand. b p-value
1 0.060 0.197 <0.001 0.054 0.248 <0.001
1 0.006 0.192 <0.001 0.004 0.186 <0.001
0.002 0.029 0.546 0.005 0.094 0.050
0.008 0.054 0.233 0.003 0.027 0.545
0.104 0.080 0.068 0.090 0.098 0.023
1 0.059 0.192 <0.001 0.052 0.238 <0.001
1 0.006 0.192 <0.001 0.004 0.186 <0.001
0.002 0.026 0.580 0.005 0.088 0.066
0.010 0.061 0.187 0.004 0.041 0.369
0.003 0.036 0.446 0.004 0.071 0.129
0.100 0.077 0.079 0.084 0.093 0.031
1 0.049 0.158 <0.001 0.042 0.193 <0.001
1 0.006 0.193 <0.001 0.004 0.188 <0.001
0.003 0.033 0.491 0.006 0.099 0.035
0.009 0.071 0.206 0.003 0.031 0.476
1 0.001 0.136 0.002 0.001 0.194 <0.001
0.092 0.070 0.103 0.078 0.085 0.044
model. Log dienes ¼ Logarithmic transformed serum LDL conjugated dienes. As the
pected proportional IMT increment for a unit increment of the determinant (e.g.
f the determinant).
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Fig. 1. Association between geometric latitude of the study centers and subjects’
serum LDL conjugated dienes (logarithmic transformed), mean  SD. Correlation
coefﬁcient for linear trend across latitude from northern to southern study centers is
0.39, p < 0.0001.
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LDL particles [20] or other markers of oxidative stress [21]. In this
IMPROVE data, statin treatment had a weak, but signiﬁcant inverse
correlation with LDL conjugated dienes. LDL cholesterol concen-
tration was not directly measured, but calculated by Friedewald’s
formula, which may have some limitations in establishing LDL
cholesterol associations.
Smoking expressed as pack-years was a signiﬁcant determinant
of IMT in this study. Tobacco smoke can increase the oxidative
modiﬁcation of LDL in vitro [22] and in vivo [23], but on the other
hand, protecting effects of cigarette smoke on LDL oxidative
modiﬁcation have been observed [24]. In our study, pack-years of
smoking appeared not to be related in the oxidative modiﬁcation of
LDL lipids. In a recent study, overweight was the least important
risk factor of IMT, followed by smoking, when only ﬁve risk factors
were included in the analysis [25]. On the other hand obesity was
shown to be the greatest risk factor, followed by hypertension. In
this IMPROVE substudy, BMI did not associate with any IMT vari-
able, but correlated signiﬁcantly with LDL conjugated dienes. In
previous studies, overweight or obesity has been related to the LDL
conjugated dienes [26]. In obese women and men, weight loss
reduced circulating LDL conjugated dienes by 20e40% [27,28]. In
a Finnish elderly population study, we did not ﬁnd signiﬁcant
association between BMI and LDL conjugated dienes inmultivariate
models, even though direct Pearson’s association exists [15].
Serum HDL cholesterol had signiﬁcant inverse Pearson’s corre-
lations with all measured IMT variables. It also associated inversely
and quite strongly with LDL conjugated dienes. This supports the
possible antioxidative role of HDL particles in circulation [29]. HDL
cholesterol as well as triglyceride concentration were not included
into the regression analysis because of the considerable cross-
correlation with LDL conjugated dienes.
This multicenter study gave us the possibility to analyze the
levels of serum lipid oxidative modiﬁcation across the geographical
gradient. The subjects in North had more oxidatively modiﬁed
lipids per cholesterol in LDL particle in their circulation than the
subjects in the Southern part of Europe. This is in agreement with
the previously published IMTgradient of the whole IMPROVE study
[14], but we could not show the clear reason for the north-to-south
gradient of IMT. We can neither explain the reason for the lineargeographical trend of conjugated dienes. Of the dietary compo-
nents included in this study, only use of ﬁsh had signiﬁcant inverse
correlation with LDL conjugated dienes, and the previously pub-
lished dietary data of IMPROVE study [14] show that ﬁsh was more
often used in Southern than in Northern study centers. Fat amount
and composition in ﬁsh is dependent on ﬁsh species that, unfor-
tunately, was not recorded in this study. In addition to ﬁsh, use of
wine and fruits were more usual in South than in North, and beer
and spirits were used more often by Northern than Southern
subjects [14]. These nutritional data support our ﬁnding of
increased oxidative modiﬁcation of LDL in Northern countries, but
we could not ﬁnd any signiﬁcant association between the use of
fruits or type of alcohol drinks and LDL conjugated dienes. In
addition, the genetic basis between North and South centers may
have an important effect on the conjugated diene levels in LDL and
differences in IMT.
In the previous study concerning elderly Finnish subjects, we
found the importance of dietary carotenoids (lycopene, lutein and
b-carotene) as determinants of serum LDL conjugated dienes [15].
In IMPROVE study, the assessment of carotenoids or any vitamins
was not possible.
Measurement of LDL conjugated dienes can be considered more
“direct” method for assessing oxidative modiﬁcation of LDL in
circulation than the measurement of autoantibodies to oxidized
LDL. With immunological methods one can get either increased or
decreased values associating with IMT or other vascular outcomes,
depending on the variation in the generation of oxidized LDL used
in the measurement reagents [5e7,30]. It has also been suggested
that circulating autoantibodies to oxidatively modiﬁed LDL could
play a protective role in vivo in atherosclerosis [5,6].
The IMPROVE study protocol was prepared to include only “high
risk” subjects which could weaken the association because of
missing of the “healthy” subjects. It is therefore likely that the
association might be even stronger in a population-based study. A
limitation of this study is the incomplete dietary questionnaire
with the lack of detailed information of the nutritional factors that
may inﬂuence on body oxidative status. This gap in knowledge
could serve as basis for future studies. However, the strengths of
IMPROVE study are obvious: a tight control of the methodology for
carotid image acquisition and measurement of IMTs, a large sample
size, a broad scale of measurement of many potentially important
vascular risk factors and furthermore centralized biochemical
analysis of blood samples, which diminishes the variation of the
assays.
In conclusion, this study shows cross-sectional associations
between increased LDL oxidative modiﬁcation and subclinical
atherosclerosis after adjustments for traditional risk factors. It
seems that the early step of oxidative modiﬁcation of the fatty
acids in LDL molecule is an important risk factor for atheroscle-
rosis. Subjects in Northern countries of Europe had more oxida-
tively modiﬁed lipids per cholesterol in LDL particle than subjects
in Southern countries. This might partly be due to a healthier diet
in south than in north, difference in other life style factors or
differences in genetic basis, but the exact reasons behind remain
unclear.
Sources of funding
The IMPROVE study was supported by the European Commis-
sion (Contract number: QLG1-CT-2002-00896), the Swedish Heart-
Lung Foundation, the Swedish Research Council (projects 8691 and
0593), the Stockholm County Council (project 562183), Academy of
Finland (grant #110413), Finnish Society of Clinical Chemistry
(grant to K.N.), the British Heart Foundation (RG2008/014) and the
Italian Ministry of Health (Ricerca Corrente).
K. Nyyssönen et al. / Atherosclerosis 225 (2012) 231e236236Disclosures
None.
Acknowledgments
The authors warmly thank all members of the IMPROVE group
and the staff of the study centers for their excellent input to
IMPROVE study.
Appendix. The Improve Study Group
University of Milan: E.T., D.B., F.V., R. Paoletti, S. Castelnuovo,
B. Frigerio, C.R. Sirtori, M. Amato, A. Ravani, C. Tedesco, A. Discacciat;
University of Eastern Finland: K.N., S.K., J.K., T.N., R. Salonen, J. Tuo-
mainen, T.P. Tuomainen, and J. Kauhanen; Kuopio Research Institute
of Exercise Medicine: R.R., K.N., K. Huttunen, T.A. Lakka, H.M. Lakka,
I.M. Penttilä, E. Rauramaa, J. Töyry, S.B. Väisänen; Karolinska Institu-
tet: U.F., A.H., S. Zdravkovic, M. Ahl, K. Anner, G. Blomgren, K. Danell-
Toverud, M.J. Eriksson, P. Eriksson, P. Fahlstadius, G. Gråberg,
M. Heinonen, A. Holm, K. Husman, E. Kallenberg, F. Larsen, P. Matha,
R.Morgenstern, L.Nilson,A. Silveira,N. Sundgren;UniversityHospital
Groningen, Department of Medicine: A.J.S., H.J.G. Bilo, G.H. Smeets,
A.I. van Gessel, A.M van Roon, G.C. Teune, W.D. Kuipers, M. Bruin,
A. Nicolai, P. Haarsma-Jorritsma, D.J. Mulder; University of Perugia:
E.M., A. Alaeddin, D. Siepi, G. Lupattelli, G. Schillaci, G. Vaudo;
University College of London: S.H., J. Cooper, E. Hawe, J. Acharya;
Groupe Hôpital Pitie-Salpetriere, Unites de Prevention Cardiovascu-
laire: P.G., J.L. Beaudeux, J.F. Kahn, V. Carreau, A. Kontush; Bracco
Imaging: E.G.
References
[1] Steinberg D. The LDL modiﬁcation hypothesis of atherogenesis: an update.
J Lipid Res 2009;50:S376e81.
[2] Itabe H. Oxidized low-density lipoproteins: what is understood and what
remains to be clariﬁed. Biol Pharm Bull 2003;1:1e9.
[3] Hevonoja T, Pentikäinen MO, Hyvönen MT, Kovanen PE, Ala-Korpela M. Struc-
ture of low density lipoprotein (LDL) particles: basis for understanding molec-
ular changes in modiﬁed LDL. Biochim Biophys Acta 2000;1488:189e210.
[4] Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density
lipoprotein show a positive relationship with the severity of acute coronary
syndromes. Circulation 2011;103:1955e60.
[5] Weinbrenner T, Cladellas M, Covas MI, et al. The SOLOS Study Investigators.
high oxidative stress in patients with stable coronary heart disease. Athero-
sclerosis 2003;168:99e106.
[6] Karvonen J, Päivänsalo M, Kesäniemi YA, Hörkkö S. Immunoglobulin M type of
autoantibodies to oxidized low-density lipoprotein has an inverse relation to
carotid atherosclerosis. Circulation 2003;108:2107e12.
[7] Naruko T, Ueda M, Ehara S, et al. Persistent high levels of plasma oxidized low-
density lipoprotein after acute myocardial infarction predict restenosis.
Arterioscler Thromb Vasc Biol 2006;26:877e83.
[8] Ahotupa M, Ruutu M, Mäntylä E. Simple methods of quantifying oxidation
products and antioxidant potential of low density lipoproteins. Clin Biochem
1996;29:139e44.
[9] Ahotupa M, Vasankari TJ. Baseline diene conjugation in LDL lipids: an indi-
cator of circulating oxidized LDL. Free Radic Biol Med 1999;27:1141e50.[10] Toikka J, Laine H, Ahotupa M, et al. Increased arterial intimaemedia thickness
in vivo LDL oxidation in young men with borderline hypertension. Hyper-
tension 2000;36:929e33.
[11] Gavella M, Lipovac V, Car A, Vucic M. Baseline diene conjugation in LDL
lipids from newly diagnosed type 2 diabetic patients. Diabete Metab 2002;
28:391e6.
[12] Scheffer PG, Henry RMA, Wever EJM, et al. LDL oxidative modiﬁcations in
well- or moderately controlled type 2 diabetes. Diabetes Metab Res Rev 2004;
20:298e304.
[13] Kals J, Kampus P, Kals M, et al. Impact of oxidative stress on arterial elasticity
in patients with atherosclerosis. Am J Hypertens 2006;19:902e8.
[14] Baldassarre D, Nyyssönen K, Rauramaa R, et al. Cross-sectional analysis of
baseline data to identify the major determinants of carotid intimaemedia
thickness in a European population: the IMPROVE study. Eur Heart J 2010;31:
614e22.
[15] Karppi J, Nurmi T, Kurl S, Rissanen TH, Nyyssönen K. Lycopene, lutein and
b-carotene as determinants of LDL conjugated dienes in serum. Atheroscle-
rosis 2010;209:565e72.
[16] Hamed SA, Hamed EA, Hamdy R, Nabeshima T. Vascular risk factors and
oxidative stress as independent predictors of asymptomatic atherosclerosis in
adult patients with epilepsy. Epilepsy Res 2007;74:183e92.
[17] Grewal J, Anand S, Islam S, Lonn E. SHARE and SHARE-AP Investigators.
Prevalence and predictors of subclinical atherosclerosis among symptomatic
“low risk” individuals in a multiethnic population. Atherosclerosis 2008;197:
435e42.
[18] Zanchetti A, Crepaldi G, Bond MG, et al. Systolic and pulse blood pressures
(but not diastolic blood pressure and serum cholesterol) are associated
with alterations in carotid intimaemedia thickness in the moderately
hypercholesterolaemic hypertensive patients of the Plaque Hypertension
Lipid Lowering Italian Study. PHYLLIS study group. J Hypertens 2001;19:
79e88.
[19] Vasankari T, Ahotupa M, Viikari J, et al. Effects of statin therapy on circulating
conjugated dienes, a measure of LDL oxidation. Atherosclerosis 2005;179:
207e9.
[20] Homma Y, Michisita I, Hayashi H, Shigematsu H, Kanagawa Lipid Research
Group. Effects of low-dose simvastatin on the distribution of plasma choles-
terol and oxidized low-density lipoprotein in three ultracentrifugally sepa-
rated low-density lipoprotein subfractions: 12-month, open-label trial.
J Atheroscler Thromb 2010;17:1049e53.
[21] Schneider MP, Schmidt BM, John S, Schmieder RE. Effects of statin treatment
on endothelial function, oxidative stress and inﬂammation in patients with
arterial hypertension and normal cholesterol levels. J Hypertens 2011;29:
1757e64.
[22] Yamaguchi Y, Kagota S, Haginaka J, Kunitomo M. Participation of peroxynitrite
in oxidative modiﬁcation of LDL aqueous extracts of cigarette smoke. FEBS
Lett 2002;512:218e22.
[23] Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-
density lipoprotein. Circulation 1998;97:2012e6.
[24] Chen C, Loo G. Cigarette smoke extract inhibits oxidative modiﬁcation of low
density lipoprotein. Atherosclerosis 1995;112:177e85.
[25] Berni A, Giuliani A, Tartaglia F, et al. Effect of vascular risk factors on increase
in carotid and femoral intimaemedia thickness. Identiﬁcation of a risk scale.
Atherosclerosis 2011;216:109e14.
[26] Ahotupa M, Marniemi J, Lehtimäki T, et al. Baseline diene conjugation in LDL
lipids as a direct measure of in vivo LDL oxidation. Clin Biochem 1998;31:
257e61.
[27] Vasankari T, Lehtonen-Veromaa M, Möttönen T, et al. Reduced mildly
oxidized LDL in young female athletes. Atherosclerosis 2000;151:399e405.
[28] Kosola J, Ahotupa M, Kyrolainen H, Santtila M, Vasankari T. Good aerobic or
muscular ﬁtness prevents overweight men from elevated oxidized LDL. Med
Sci Sports Exerc. doi:10.1249/MSS.0b013e31823822cc.
[29] Kontush A, Chapman MJ. Antiatherogenic function of HDL particle
subpopulations: focus on antioxidative activities. Curr Opin Lipidol 2010;
21:312e8.
[30] Hulthe J, Wiklund O, Hurt-Camejo E, Bondjers G. Autoantibodies to oxidized
LDL in relation to carotid atherosclerosis, cell adhesion molecules, and
phospholipase A(2). Arterioscler Thromb Vasc Biol 2001;21:269e74.
